- 12:00 - 18/05/2026 to 14:30 - 19/05/2026
- Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom
The British Society for Immunology (BSI) Immune Therapies Summit is a unique event bringing together sector leaders from industry, academia and clinical spheres to discuss novel approaches and future challenges in immune therapies research.
The College is delighted to have approved this external event for CPD credits.
If you have any questions regarding this event, please see host's information at the bottom of this page or via the Book Now button.
TOPICS COVERED
With internationally renowned speakers and an engaging and interactive programme of 8 breakout sessions on differing hot topics, this event enables attendees to learn more about current insights and trends in immune therapy development, and be part of the conversation to drive forward the next iteration of immune therapies research for patient benefit.
WHO SHOULD ATTEND?
The BSI Immune Therapies Summit is aimed at colleagues from industry, academic and clinical research settings who are passionate about accelerating immune therapy development and building their cross-sector networks in this field.
SPEAKERS
- Shannon Turley, Amgen
- Rowann Bowcutt, UCB, UK
- Emily Corse, Noetik, USA
- John Isaacs, Newcastle University, UK
- Clare Lloyd, Imperial College London, UK
- Deborah O’Neil, NovaBiotics, UK
- Mark Peakman, Sanofi, UK
- Jeff Ravetch, The Rockerfeller University, USA
- James Zou, Stanford University, USA
For more information, please contact: [email protected].
